Table 1. PICOS criteria for eligibility of studies.

Population	Persons 60 years and over, healthy or with age-typical underlying diseases living in industrialized countries and not belonging to indigenous minority populations
Intervention	Vaccination with PPV23
Comparator	No vaccination or placebo
Outcomes	IPD and PP
Study design	RCTs Observational studies, if adjusted at least for age and comorbidities